69 related articles for article (PubMed ID: 26121332)
1. α-Aminoisobutyric acid incorporation induces cell permeability and antiviral activity of HIV-1 major homology region fragments.
Lampel A; Elis E; Guterman T; Shapira S; Marco P; Bacharach E; Gazit E
Chem Commun (Camb); 2015 Aug; 51(62):12349-52. PubMed ID: 26121332
[TBL] [Abstract][Full Text] [Related]
2. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
[TBL] [Abstract][Full Text] [Related]
3. Development of anti-HIV peptides based on a viral capsid protein.
Mizuguchi T; Ohashi N; Matsumoto D; Hashimoto C; Nomura W; Yamamoto N; Murakami T; Tamamura H
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27428649
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of cell-penetrating peptides leads to identification of anti-HIV peptides from matrix proteins.
Narumi T; Komoriya M; Hashimoto C; Wu H; Nomura W; Suzuki S; Tanaka T; Chiba J; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2012 Feb; 20(4):1468-74. PubMed ID: 22277590
[TBL] [Abstract][Full Text] [Related]
5. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.
Fader LD; Landry S; Goulet S; Morin S; Kawai SH; Bousquet Y; Dion I; Hucke O; Goudreau N; Lemke CT; Rancourt J; Bonneau P; Titolo S; Amad M; Garneau M; Duan J; Mason S; Simoneau B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3401-5. PubMed ID: 23601710
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships (SAR) research of thiourea derivatives as dual inhibitors targeting both HIV-1 capsid and human cyclophilin A.
Chen K; Tan Z; He M; Li J; Tang S; Hewlett I; Yu F; Jin Y; Yang M
Chem Biol Drug Des; 2010 Jul; 76(1):25-33. PubMed ID: 20456372
[TBL] [Abstract][Full Text] [Related]
7. Second generation, arginine-rich (R-X'-R)(4)-type cell-penetrating α-ω-α-peptides with constrained, chiral ω-amino acids (X') for enhanced cargo delivery into cells.
Patil KM; Naik RJ; Vij M; Yadav AK; Kumar VA; Ganguli M; Fernandes M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4198-202. PubMed ID: 25096299
[TBL] [Abstract][Full Text] [Related]
8. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
[TBL] [Abstract][Full Text] [Related]
9. Cellular uptake of Aib-containing amphipathic helix peptide.
Wada S; Tsuda H; Okada T; Urata H
Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
[TBL] [Abstract][Full Text] [Related]
10. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid.
Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M
Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002
[TBL] [Abstract][Full Text] [Related]
11. Potent leads based on CA-19L, an anti-HIV active HIV-1 capsid fragment.
Tsuji K; Wang R; Kobayakawa T; Owusu KB; Fujino M; Kaneko M; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2021 Jan; 30():115923. PubMed ID: 33316719
[TBL] [Abstract][Full Text] [Related]
12. Development of 2-aminoisobutyric acid (Aib)-rich cell-penetrating foldamers for efficient siRNA delivery.
Misawa T; Ohoka N; Oba M; Yamashita H; Tanaka M; Naito M; Demizu Y
Chem Commun (Camb); 2019 Jul; 55(54):7792-7795. PubMed ID: 31210205
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4.
Hashimoto C; Nomura W; Narumi T; Fujino M; Tsutsumi H; Haseyama M; Yamamoto N; Murakami T; Tamamura H
ChemMedChem; 2013 Oct; 8(10):1668-72. PubMed ID: 24039179
[TBL] [Abstract][Full Text] [Related]
14. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
Neira JL
FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly.
Fader LD; Bethell R; Bonneau P; Bös M; Bousquet Y; Cordingley MG; Coulombe R; Deroy P; Faucher AM; Gagnon A; Goudreau N; Grand-Maître C; Guse I; Hucke O; Kawai SH; Lacoste JE; Landry S; Lemke CT; Malenfant E; Mason S; Morin S; O'Meara J; Simoneau B; Titolo S; Yoakim C
Bioorg Med Chem Lett; 2011 Jan; 21(1):398-404. PubMed ID: 21087861
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins.
Mizuguchi T; Ohashi N; Nomura W; Komoriya M; Hashimoto C; Yamamoto N; Murakami T; Tamamura H
Bioorg Med Chem; 2015 Aug; 23(15):4423-4427. PubMed ID: 26094944
[TBL] [Abstract][Full Text] [Related]
17. Aib-containing peptide analogs: cellular uptake and utilization in oligonucleotide delivery.
Wada S; Urase T; Hasegawa Y; Ban K; Sudani A; Kawai Y; Hayashi J; Urata H
Bioorg Med Chem; 2014 Dec; 22(24):6776-80. PubMed ID: 25468041
[TBL] [Abstract][Full Text] [Related]
18. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein.
Tian B; He M; Tang S; Hewlett I; Tan Z; Li J; Jin Y; Yang M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2162-7. PubMed ID: 19297155
[TBL] [Abstract][Full Text] [Related]
20. [Antibacterial activity and mechanisms of a new peptide derived from cell-penetrating peptide].
Li L; Shi Y; Le G
Wei Sheng Wu Xue Bao; 2013 Sep; 53(9):950-6. PubMed ID: 24377247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
